U.S. biotech firm Moderna’s early findings on a coronavirus vaccine reportedly does not provide critical data needed to evaluate its effectiveness.
— Read on world.kbs.co.kr/service/news_view.htm

Given this information, why is everyone so eager to accept a vaccine for COVID-19 when no other coronaviruses have vaccines? Why are investors rallying behind this company?

Here’s a clue:

“They also pointed out that were was not enough comment on the vaccine from Moderna’s U.S. government partner, the National Institute for Allergy and Infectious Diseases.“